# Infinix

> Infinix is Nobio Ltd.’s dental restorative brand, combining composites and a primer-and-bond system with embedded, non-leaching QASi antibacterial filler. It sells materials to dental professionals, with published studies supporting antibacterial activity and reduced demineralization under specific experimental conditions.

- **Founded:** 2015
- **Headquarters:** Kadima, Israel
- **Founders:** Ervin Weiss (Co-founder; dental researcher), Julia Rothman (Co-founder (listed by IVC))
- **Products:** Infinix Universal Composite, Infinix Flowable Composite, Infinix Bulk Fill Flow Composite, Infinix Universal Prime & Bond, Infinix Starter Kit
- **Notable:** FDA clearances for flowable and bulk-fill composites announced in 2019., FDA K201010 cleared the composite family with a demineralization-reduction indication in August 2020., Cellerant Best of Class Technology Awards in 2020 and 2021, according to Nobio’s announcement.

## Products & services

- **Infinix Universal Composite** — Light-cured restorative composite with embedded QASi antibacterial filler; current online listing $172.
- **Infinix Flowable Composite** — Flowable restorative composite with QASi; current online listing $97.
- **Infinix Bulk Fill Flow Composite** — Bulk-fill flowable restorative material; current listing $97 for a 2 g syringe.
- **Infinix Universal Prime & Bond** — Two-component self-etch adhesive system with a primer and light-cured bonding agent; current listing $197.
- **Infinix Starter Kit** — Bundle introducing the restorative system; listed at $466 regular price and $396 promotional price on the research date.

## Achievements

- FDA clearances for flowable and bulk-fill composites announced in 2019.
- FDA K201010 cleared the composite family with a demineralization-reduction indication in August 2020.
- Cellerant Best of Class Technology Awards in 2020 and 2021, according to Nobio’s announcement.
- Peer-reviewed in-situ mineral-loss study published in 2021.
- Infinix Flowable Composite served as the primary predicate in Premier’s November 2025 FDA K253513 filing.

## Latest updates

- **2025-10** — Journal of Dentistry published an ex-vivo study of pH dynamics using saliva from 34 high-caries-risk children; it tested materials outside patients’ mouths.
- **2025-11** — FDA cleared Premier MultiMatch Flow Chameleon AntiMicrobial Composite, whose filing identifies Infinix Flowable Composite as its primary predicate.

## Links

- Website: https://www.infinix.com/
- LinkedIn: https://www.linkedin.com/company/nobio
- YouTube: https://www.youtube.com/@nobiolabs
- Instagram: https://www.instagram.com/nobio.labs/
- Facebook: https://www.facebook.com/profile.php?id=61567877609489

---

Profile page: https://yespress.io/infinix
Published by YesPress — https://yespress.io
Last updated: 2026-10-16